Skip to content
Back to announcement

20250725_SDPC_Laporan Informasi dan Fakta Material_31917610_lamp1.pdf

Other Text extracted SDPC

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1 OCR 0.927
aa

PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

Jakarta, 25 Juli 2025

No : 532/MPI/DIR/VII/2025
Lamp. : -—

Kepada Yth., / To.
1. Otoritas Jasa Keuangan
Gedung Soemitro Djojohadikusumo
Jalan Lapangan Banteng Timur 2-4
Jakarta 10710
U.P. : Kepala Eksekutif Pengawas Pasar Modal

2. PT Bursa Efek Indonesia
Indonesia Stock Exchange Building, Tower 1
Jl. Jend. Sudirman Kav. 52-53
Jakarta 12190
U.P. : Kepala Penilaian Perusahaan 3

Perihal: Keterbukaan Informasi — Pemberhentian Kerjasama Distribusi

Dengan hormat,

Merujuk pada (i) Peraturan Ototritas Jasa Keuangan (“OJK”) Nomor 45 Tahun 2024 tentang
Pengembangan dan Penguatan Bmiten dan Perusahaan Publik, dan (ii) peraturan nomor I-E tentang
Perubahan Peraturan Nomor I-E tentang Kewajiban Penyampaian Informasi, Keputusan Direksi PT. Bursa
Efek Indonesia Nomor : Kep-00066/BEI/09-2022 tanggal 30 September 2022 (“Peraturan I-E”), bersama
ini kami sampaikan bahwa PT. Millennium Pharmacon International Tbk telah sepakat dengan PT. Starnegy
untuk mengakhiri kerjasama distribusi secara resmi.

Referring to (i) Financial Service Authority (“OJK”) Regulation Number 45 of 2024 concerning the
Development and Strengthening of Issuer and Public Companies: and (ii) Rule Number LE regarding
amendments to Regulation Number I-E regarding Obligation to Submit Information, the Decree of Board
of Directors of PT Bursa Efek Indonesia No. KEP-00066/BEI/09-2022 dated 30 September 2022 (“Rule I-
FE”), we hereby inform that PT Millennium Pharmacon International Tbk and PT Starnegy have agreed to
Officially end the distribution cooperation.

Tidak terdapat dampak yang signifikan terhadap operasional dan kelangsungan usaha perseroan atas
pemberhentian kerjasama distribusi ini.

There is no significant impact on the company's operations and business continuily with the termination of
this distribution cooperation.

Crown Bungur Arteri 2-4th Floors
Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia
Phone : #6221 27085961

Page 2 OCR 0.922
Nama

PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

Demikian pemberitahuan ini disampaikan.Atas perhatiannya kami ucapkan terima kasih.
Thus, we informed this disclosure. Thank you for your attention.

Hormat kami,
PT Millennium Pharmacon International Tbk

Grown Bungur Arteri 2-4th Floors
Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia
Phone : #6221 27085961

File

File Open PDF
Source IDX
Size0.49 MB
Published25 Jul 2025
Pages2
Characters2,352
Text sourceOCR
OCR confidence0.924

Names mentioned 6 people and organisations named in the text · linked when the evidence is strong

possible org Otoritas Jasa Keuangan p.1
possible org PT Bursa Efek Indonesia p.1 ×3
unresolved org PT Bursa Efek Indonesia Indonesia Stock Exchange Building p.1
unresolved org Indonesia Stock Exchange p.1
unresolved org PT. Starnegy p.1 ×2

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

Other files in this announcement 1

↑↓ select ↵ open ⇧↵ see every result